Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT00899951
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of cancer
* Inpatient at the Johns Hopkins Hospital Cancer Center undergoing pain treatment with continuous infusion fentanyl citrate for ≥ 5 days
PATIENT CHARACTERISTICS:
* Willing to change to an alternative opioid
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* At least 72 hours since transdermal fentanyl citrate administration
* At least 12 hours since transmucosal fentanyl citrate administration
* No known requirement for continued opioid therapy with any fentanyl citrate products after discontinuation of fentanyl citrate therapy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00899951
Study Brief:
Protocol Section:
NCT00899951